Stock listing

BIOAB Stock Price, News, Filings & Events — Bioarctic Ab Class B

Selected listing: BIOAB · OMXSTO · SEK · SE

This page tracks Bioarctic Ab Class B's BIOAB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOAB:OMXSTO. BIOAB:OMXSTO is the stock-level entry point for investors researching Bioarctic Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioarctic Ab Class B is a public company listed on the Swedish market under the ticker BIOA B. The company has a market capitalization of approximately 2.78 billion SEK. Bioarctic focuses on developing innovative treatments for neurodegenerative diseases, leveraging its expertise in biotechnology.

BIOAB:OMXSTOSEKSEUpdated August 22, 2026
Bioarctic Ab Class B logo
Ticker
BIOA_B:OMXSTO
Asset type
Stock
Market cap
$3.14B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK

Bioarctic Ab Class B BIOAB:OMXSTO stock context

This page tracks Bioarctic Ab Class B's BIOAB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOAB:OMXSTO. BIOAB:OMXSTO is the stock-level entry point for investors researching Bioarctic Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioarctic Ab Class B is a public company listed on the Swedish market under the ticker BIOA B. The company has a market capitalization of approximately 2.78 billion SEK. Bioarctic focuses on developing innovative treatments for neurodegenerative diseases, leveraging its expertise in biotechnology.

Latest news from Bioarctic Ab Class B

All Bioarctic Ab Class B news →

Bioarctic Ab Class B earnings calls

Research Bioarctic Ab Class B

Alternate listings